Eiger BioPharmaceuticals, Inc. (EIGR) Social Stream
EIGER BIOPHARMACEUTICALS INC (EIGR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering EIGER BIOPHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 4 | $49 | $21 | $31.25 | $0.23 | 13486.96% |
| 2022-03-11 | 4 | $28 | $21 | $25.333 | $0.23 | 10914.35% |
| 2022-08-05 | 3 | $29 | $22 | $26 | $0.23 | 11204.35% |
| 2022-08-07 | 3 | $29 | $21 | $25.666 | $0.23 | 11059.13% |
| 2022-11-04 | 3 | $48 | $21 | $32.333 | $0.23 | 13957.83% |
| 2022-11-14 | 3 | $48 | $20 | $32 | $0.23 | 13813.04% |
| 2022-12-09 | 3 | $48 | $3 | $20.6 | $0.23 | 8856.52% |
| 2022-12-13 | 3 | $20 | $3 | $9.2 | $0.23 | 3900% |
| 2023-05-12 | 3 | $9 | $3 | $5.5 | $0.23 | 2291.3% |
| 2023-08-16 | 3 | $9 | $1 | $4.75 | $0.23 | 1965.22% |
| 2023-11-13 | 4 | $5 | $1 | $3 | $0.23 | 1204.35% |
The Trend in the Analyst Price Target
EIGR's average price target has moved down $21.5 over the prior 19 months.
EIGR reports an average of 692.98% for its upside potential over the past 34 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-30 | 3 | 9 | 1 | 4.75 | 0.704 | 574.72% |
| 2023-08-16 | 4 | 9 | 1 | 4.75 | 0.700 | 578.57% |
| 2023-08-16 | 3 | 9 | 1 | 4.75 | 0.700 | 578.57% |
| 2023-08-29 | 4 | 9 | 1 | 4.50 | 0.848 | 430.66% |
| 2023-11-13 | 4 | 9 | 1 | 4.50 | 0.303 | 1385.15% |
EIGR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 52 weeks, EIGR's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how EIGER BIOPHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1790.33% of that group.
- In terms of how EIGER BIOPHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 153.64% of that group.
- In terms of how EIGER BIOPHARMACEUTICALS INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -1075.17% of that group.
- In the context of stocks in the small market cap category, EIGER BIOPHARMACEUTICALS INC's average analyst price target is higher than 786.63% of them.
Stocks similar to EIGER BIOPHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are OCGN, ADVM, and CGEN.
View All Top Stocks by Price Target
Make investment decisions regarding EIGR using the data that counts. Try POWR Ratings for free.